CAPS Rating

Fanjiemeng (95.25)

Results 1 - 20 of 39 : 1 2 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
20/06/2012 KRO.US 5 out of 5 Outperform 5Y $16.68 $16.28 (+0.49%) -2.42% +23.25% -25.67
07/05/2012 GMCR.US 2 out of 5 Outperform 5Y $25.84 $80.22 (+0.77%) +210.45% +22.02% +188.43
03/01/2012 MPR.US 4 out of 5 Outperform 5Y $8.87 $13.53 (-0.29%) +52.53% +30.66% +21.87
06/12/2011 AEO.US 4 out of 5 Outperform 5Y $13.16 $20.21 (+0.80%) +53.53% +32.26% +21.26
06/12/2011 DWA.US 4 out of 5 Outperform 5Y $17.90 $21.93 (+0.87%) +22.51% +32.26% -9.75
06/12/2011 AFAM.US 5 out of 5 Outperform 5Y $13.88 $19.62 (-0.76%) +41.38% +32.26% +9.12
06/12/2011 GPS.US 2 out of 5 Outperform 5Y $18.59 $41.06 (+0.24%) +120.86% +32.26% +88.59
06/12/2011 PETS.US 4 out of 5 Outperform 5Y $7.80 $12.94 (-1.67%) +65.98% +32.26% +33.72
06/12/2011 RCL.US 2 out of 5 Outperform 5Y $27.67 $37.81 (+0.72%) +36.62% +32.26% +4.36
06/12/2011 JPM.US 4 out of 5 Outperform 5Y $31.88 $52.29 (-0.02%) +64.00% +32.26% +31.74
07/10/2011 GSK.US 4 out of 5 Outperform 5Y $39.09 $52.21 (-0.02%) +33.56% +42.47% -8.91
07/10/2011 BAC.US 4 out of 5 Outperform 5Y $6.00 $13.51 (+0.60%) +125.01% +42.47% +82.54
07/10/2011 ANF.US 1 out of 5 Outperform 5Y $63.40 $54.41 (+0.31%) -14.18% +42.47% -56.65
07/10/2011 T.US 3 out of 5 Outperform 5Y $26.55 $37.22 (-0.59%) +40.19% +42.47% -2.28
07/10/2011 AZN.US 4 out of 5 Outperform 5Y $41.35 $51.50 (-0.12%) +24.54% +42.47% -17.93
05/10/2011 NC.US 5 out of 5 Outperform 5Y $18.99 $54.46 (+0.52%) +186.73% +48.22% +138.51
05/10/2011 PL.US 3 out of 5 Outperform 5Y $14.11 $38.71 (-0.36%) +174.43% +48.22% +126.20
04/10/2011 WFC.US 4 out of 5 Outperform 5Y $21.97 $40.20 (+0.80%) +82.95% +51.62% +31.33
04/10/2011 IBOC.US 2 out of 5 Outperform 5Y $12.09 $21.81 (+1.11%) +80.39% +54.07% +26.33
04/10/2011 NYCB.US 4 out of 5 Outperform 5Y $9.89 $13.91 (+0.94%) +40.58% +54.07% -13.49
Results 1 - 20 of 39 : : 1 2 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.